Who’s Next In Congressional Hot Seat? Pharma Industry Could Replace FDA
Executive Summary
Congress will not keep up its intense scrutiny of FDA when President-elect Barack Obama takes office, drug and device lawyers predict. Instead, Capitol Hill will shift its attention to pharmaceutical company practices
You may also be interested in...
GSK Avodart TV Ad Cited By FDA For Out-Of-This World Efficacy Comparison
FDA's letter to GlaxoSmithKline about a planetarium-themed TV spot for Avodart demonstrates several of the reasons that direct-to-consumer advertising remains in a troubled orbit above the pharmaceutical industry
GSK Avodart TV Ad Cited By FDA For Out-Of-This World Efficacy Comparison
FDA's letter to GlaxoSmithKline about a planetarium-themed TV spot for Avodart demonstrates several of the reasons that direct-to-consumer advertising remains in a troubled orbit above the pharmaceutical industry
PhRMA’s Revised DTC Code Shies Away From Internet; Not Celebrities
The Pharmaceutical Research and Manufacturers of America's revised guidelines for direct-to-consumer advertising steer clear of the Internet, even as drug ads are a growing presence on the Web